533029 logo

Alkali Metals Limited Stock Price

BSE:533029 Community·₹851.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

533029 Share Price Performance

₹83.63
-32.82 (-28.18%)
₹83.63
-32.82 (-28.18%)
Price ₹83.63

533029 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks
0 Rewards

Alkali Metals Limited Key Details

₹865.9m

Revenue

₹455.4m

Cost of Revenue

₹410.5m

Gross Profit

₹436.9m

Other Expenses

-₹26.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-2.60
47.40%
-3.06%
44.0%
View Full Analysis

About 533029

Founded
1968
Employees
106
CEO
Yerramilli Srirama R. Rao
WebsiteView website
www.alkalimetals.com

Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company’s products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.

Recent 533029 News & Updates

Recent updates

No updates